Child Study Center—Manhattan | NYU Langone Health
The Child Study Center—Manhattan is part of Hassenfeld Children’s Hospital at NYU Langone.
Child Study Center—New Jersey | NYU Langone Health
The Child Study Center—New Jersey is part of Hassenfeld Children’s Hospital at NYU Langone.
Child Study Center Webinars | NYU Langone Health
NYU Langone’s Child Study Center hosts webinars on topics related to children’s emotional health and parenting.
Childhood Cancers & Blood Disorders We Treat | NYU Langone Health
At NYU Langone’s Stephen D. Hassenfeld Children’s Center for Cancer and Blood Disorders, we provide expert treatment for many conditions.
Childhood Conditions We Treat | NYU Langone Health
Doctors at Hassenfeld Children’s Hospital at NYU Langone diagnose and treat all types of childhood medical conditions.
Childhood Stories from Our Pediatric Experts | NYU Langone Health
Watch doctors at Hassenfeld Children’s Hospital at NYU Langone discuss what inspired them to care for children.
Children Caregivers and Community: Together Growing Strong Family Trajectory Study
The purpose of this study is to learn about parents, families, and programs that help children build the skills they need to be ready for school.
Children s Awareness and Long-Term Quality of Life: A Mixed Methods Study of Pediatric Critical Care Unit (PICU) Experiences
The purpose of this study is to learn more about memories and/or experiences that children may have had during life threatening illness in the Pediatric Intensive Care Unit (PICU). Some children who have gained consciousness after experiencing a life threatening illness in the PICU have reported memories, experiences, and awareness during the period in which they were unconscious. These may include peaceful feelings, a perception of a tunnel and/or a light, seeing relatives, a life review, and positive emotions.
Choosing Vaginal Birth After Cesarean | NYU Langone Health
NYU Langone doctors determine if a woman is a candidate for vaginal birth after cesarean, or VBAC, based on her medical and surgical history.
CHORD1 CHOlesterol Lowering and Residual Risk in Diabetes Type 1
This is a prospective, interventional, cohort study, meaning that researchers will follow and observe a group of enrolled study participants over a period of time (one to two months) to gather information and record any developments of the outcomes in question.This study will recruit 125 participants with Type 1 Diabetes (T1D) to:1. Analyze the effect of reducing the cholesterol levels in the blood on platelet function. (Platelets are small cells in the blood which help form blood clots to slow or stop bleeding and to help wounds heal2. Analyze the effect of reducing the cholesterol levels in the blood on While Blood Cell (WBC) gene expression, (White Blood Cells are part of the body's immune system which help the body fight infection and other diseases) and 3. Analyze the effect of reducing the cholesterol levels in the blood on vascular or blood vessel function. Participants will receive weekly injections of PCSK9i (evolocumab) plus daily, oral pills of atorvastatin or ezetimibe for 1 month. Participants will undergo blood draw, and optional vascular studies that includes:- Glycocalyx testing (A non-invasive test where a video microscope camera is placed under the tongue to capture images of the movement of red blood cells as they travel through the micro-blood vessels)- PET/CT for vascular imaging - to assess any inflammation of blood vessels and to evaluate increased metabolism in related tissues, and - Endothelial cell collection before cholesterol reduction and 1-month after cholesterol reduction to measure any genetic changes in in the endothelial cells before and after collectionGlycemic Variability (GV), the amount one's blood sugar changes throughout the day, will be analyzed from continuous glucose monitoring (CGM) data. Participants will be enrolled from NYU Langone Health, including the Faculty Group Practice, (e.g. NYU Center for the Prevention of CVD, Division of Endocrinology, and Diabetes Clinic at Winthrop) as well as Bellevue Hospital. Additionally, we will work with collaborators at Icahn School of Medicine at Mount Sinai (ISMMS).